Towards comprehensive and quantitative proteomics for diagnosis and therapy of human disease
- PMID: 27775219
- PMCID: PMC5243792
- DOI: 10.1002/pmic.201600079
Towards comprehensive and quantitative proteomics for diagnosis and therapy of human disease
Abstract
Given superior analytical features, MS proteomics is well suited for the basic investigation and clinical diagnosis of human disease. Modern MS enables detailed functional characterization of the pathogenic biochemical processes, as achieved by accurate and comprehensive quantification of proteins and their regulatory chemical modifications. Here, we describe how high-accuracy MS in combination with high-resolution chromatographic separations can be leveraged to meet these analytical requirements in a mechanism-focused manner. We review the quantification methods capable of producing accurate measurements of protein abundance and posttranslational modification stoichiometries. We then discuss how experimental design and chromatographic resolution can be leveraged to achieve comprehensive functional characterization of biochemical processes in complex biological proteomes. Finally, we describe current approaches for quantitative analysis of a common functional protein modification: reversible phosphorylation. In all, current instrumentation and methods of high-resolution chromatography and MS proteomics are poised for immediate translation into improved diagnostic strategies for pediatric and adult diseases.
Keywords: Biomedicine; Functional proteomics; Mass spectrometry; PTM; Pediatric disease; Protein quantification.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Ridker PM. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin Chem. 2009 Feb;55(2):209–215. - PubMed
-
- Lassman ME, McAvoy T, Chappell DL, Lee AY, Zhao XX, Laterza OF. The clinical utility of mass spectrometry based protein assays. Clin Chim Acta. 2016 Aug;459:155–161. - PubMed
-
- Adaway JE, Keevil BG, Owen LJ. Liquid chromatography tandem mass spectrometry in the clinical laboratory. Ann Clin Biochem. 2015 Jan;52(1):18–38. - PubMed
-
- Ombrone D, Giocaliere E, Forni G, Malvagia S, la Marca G. Expanded newborn screening by mass spectrometry: New tests, future perspectives. Mass Spectrom Rev. 2016 Jan;35(1):71–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
